swisspartners’s Idexx Laboratories IDXX Stock Holding History

swisspartners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-450	Closed	-$246K	–	83
2022 Q1	$246K	Hold	450	–	–	0.19%	72
2021 Q4	$300K	Hold	450	–	–	0.21%	71
2021 Q3	$280K	Buy	+450	New	+$302K	0.22%	67

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

swisspartners's IDXX Position: Q2 2022 in Review

swisspartners sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 450 shares — an estimated $246K sold.

swisspartners first reported a position in IDXX in Q3 2021 and held it in 3 quarters. The position peaked at $300K in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

swisspartners reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
swisspartners sold 450 Idexx Laboratories shares in Q2 2022, an estimated $246K.
swisspartners first reported a position in Idexx Laboratories in Q3 2021 and held it in 3 quarters.
swisspartners's Idexx Laboratories position peaked at $300K in Q4 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on swisspartners's 13F filing for Q2 2022, filed 10 Aug 2022.